Endo International | ENDP - Aktuelle Verpflichtungen



Aktuelle Verpflichtungen Veränderung Datum
AbbVie USD 41.64B 458M 2026-06
Amarin USD 164.2M 15.45M 2026-06
ANI Pharmaceuticals USD 283.65M 44.14M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Coherus Biosciences USD 75.51M 56.82M 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Heron Therapeutics USD 92.14M 1.63M 2026-06
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Ligand Pharmaceuticals USD 46.74M 6.07M 2026-06
Merck USD 27.73B 786M 2026-06
Novartis USD 31.75B 374M 2026-06
Pacira USD 122.01M 13.22M 2026-06
Perrigo USD 1.05B 57.2M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Phibro Animal Health USD 316.47M 34.6M 2026-06
Supernus Pharmaceuticals USD 347.38M 26.55M 2026-06
Takeda JPY 2.76T 335.02B 2026-06
Teva Pharmaceutical Industries USD 15.65B 2.11B 2026-06
Xeris Pharmaceuticals USD 189.57M 70.97M 2026-06
Zoetis USD 2.06B 8M 2026-06